Decision Interest Expense from 2010 to 2026

DECN Stock  USD 0.0001  0.00  0.00%   
Decision Diagnostics Interest Expense yearly trend continues to be very stable with very little volatility. Interest Expense is likely to grow to about 32.9 M this year. Interest Expense is the cost incurred by an entity for borrowed funds, including loans, bonds, or lines of credit. View All Fundamentals
 
Interest Expense  
First Reported
2009-03-31
Previous Quarter
64.2 K
Current Value
64.2 K
Quarterly Volatility
939.7 K
 
Credit Downgrade
 
Yuan Drop
 
Covid
 
Interest Hikes
Check Decision Diagnostics financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Decision Diagnostics' main balance sheet or income statement drivers, such as Interest Expense of 32.9 M, Selling General Administrative of 2.6 M or Total Revenue of 1.7 M, as well as many indicators such as Price To Sales Ratio of 2.65, Dividend Yield of 0.068 or PTB Ratio of 7.9. Decision financial statements analysis is a perfect complement when working with Decision Diagnostics Valuation or Volatility modules.
  
Build AI portfolio with Decision Stock
Check out the analysis of Decision Diagnostics Correlation against competitors.
To learn how to invest in Decision Stock, please use our How to Invest in Decision Diagnostics guide.
Evaluating Decision Diagnostics's Interest Expense across multiple reporting periods reveals the company's ability to sustain growth and manage resources effectively. This longitudinal analysis highlights inflection points, cyclical patterns, and structural changes that short-term snapshots might miss, offering deeper insight into Decision Diagnostics's fundamental strength.

Latest Decision Diagnostics' Interest Expense Growth Pattern

Below is the plot of the Interest Expense of Decision Diagnostics over the last few years. It is the cost incurred by an entity for borrowed funds, including loans, bonds, or lines of credit. Decision Diagnostics' Interest Expense historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Decision Diagnostics' overall financial position and show how it may be relating to other accounts over time.
Interest Expense10 Years Trend
Slightly volatile
   Interest Expense   
       Timeline  

Decision Interest Expense Regression Statistics

Arithmetic Mean11,976,614
Geometric Mean0.00
Coefficient Of Variation120.88
Mean Deviation13,735,363
Median0.00
Standard Deviation14,477,682
Sample Variance209.6T
Range32.9M
R-Value0.88
Mean Square Error49.9T
R-Squared0.78
Slope2,527,206
Total Sum of Squares3353.7T

Decision Interest Expense History

202632.9 M
202531.4 M
202027.3 M
2019M

About Decision Diagnostics Financial Statements

Decision Diagnostics investors utilize fundamental indicators, such as Interest Expense, to predict how Decision Stock might perform in the future. Analyzing these trends over time helps investors make informed market timing decisions. For further insights, please visit our fundamental analysis page.
Last ReportedProjected for Next Year
Interest Expense31.4 M32.9 M
When determining whether Decision Diagnostics offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Decision Diagnostics' financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Decision Diagnostics Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Decision Diagnostics Stock:
Check out the analysis of Decision Diagnostics Correlation against competitors.
To learn how to invest in Decision Stock, please use our How to Invest in Decision Diagnostics guide.
You can also try the Bollinger Bands module to use Bollinger Bands indicator to analyze target price for a given investing horizon.
Will Health Care Technology sector continue expanding? Could Decision diversify its offerings? Factors like these will boost the valuation of Decision Diagnostics. Projected growth potential of Decision fundamentally drives upward valuation adjustments. Accurate valuation requires analyzing both current fundamentals and future growth trajectories. Every Decision Diagnostics data point contributes insight, yet successful analysis hinges on identifying the most consequential variables.
Earnings Share
(0.02)
Revenue Per Share
0.006
Quarterly Revenue Growth
(0)
Return On Assets
(0.21)
Return On Equity
(81.61)
Understanding Decision Diagnostics requires distinguishing between market price and book value, where the latter reflects Decision's accounting equity. The concept of intrinsic value - what Decision Diagnostics' is actually worth based on fundamentals - guides informed investors toward better entry and exit points. Seasoned market participants apply comprehensive analytical frameworks to derive fundamental worth and identify mispriced opportunities. Market sentiment, economic cycles, and investor behavior can push Decision Diagnostics' price substantially above or below its fundamental value.
It's important to distinguish between Decision Diagnostics' intrinsic value and market price, which are calculated using different methodologies. Investment decisions regarding Decision Diagnostics should consider multiple factors including financial performance, growth metrics, competitive position, and professional analysis. In contrast, Decision Diagnostics' trading price reflects the actual exchange value where willing buyers and sellers reach mutual agreement.